Aether THERAPEUTICS
About this raise: Aether THERAPEUTICS, with a valuation of $17.5 million, is raising funds on NetCapital. The company is developing safe opioid pain therapy without the fear of addiction. Aether THERAPEUTICS’s low-dose ATX-001 is focused on breaking the chain of addiction while not blocking pain relief or causing withdrawal and other adverse effects. ATX-001 is a metabolite of naltrexone and has undergone pre-clinical testing on canines with no toxic effects. Wolfgang Sadee founded Aether THERAPEUTICS in December 2017. The current crowdfunding campaign has a minimum target of $10,002.24 and a maximum target of $800,032. The campaign proceeds will be used for animal testing, initial production of API, hiring, legal fees, and patents.
Investment Overview
Invested : $209,668
Deal Terms
Total Commitments ($USD)
- Platform
- Netcapital
- Start Date
- 08/21/2024
- Close Date
- 12/06/2024
$10,002
$800,032
$99
Equity - Common
Seed
RegCF
$3.68
$17,486,944
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Low
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $2,000,000
- Grants
- $4,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Netcapital | $17,486,944 | $209,668 | Equity - Common | Funded | RegCF |